Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Untargeted DNA-based methods for the authentication of wheat species and related cereals in food products.

Silletti S, Morello L, Gavazzi F, Gianì S, Braglia L, Breviario D.

Food Chem. 2019 Jan 15;271:410-418. doi: 10.1016/j.foodchem.2018.07.178. Epub 2018 Jul 27.

PMID:
30236695
2.

Root inoculation with Azotobacter chroococcum 76A enhances tomato plants adaptation to salt stress under low N conditions.

Van Oosten MJ, Di Stasio E, Cirillo V, Silletti S, Ventorino V, Pepe O, Raimondi G, Maggio A.

BMC Plant Biol. 2018 Sep 20;18(1):205. doi: 10.1186/s12870-018-1411-5.

3.

A Benzimidazole Proton Pump Inhibitor Increases Growth and Tolerance to Salt Stress in Tomato.

Van Oosten MJ, Silletti S, Guida G, Cirillo V, Di Stasio E, Carillo P, Woodrow P, Maggio A, Raimondi G.

Front Plant Sci. 2017 Jul 18;8:1220. doi: 10.3389/fpls.2017.01220. eCollection 2017.

4.

α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5.

Lee CY, Marzan D, Lin G, Goodison S, Silletti S.

J Oncol. 2011;2011:365651. doi: 10.1155/2011/365651. Epub 2011 Dec 13.

5.

Modification of the L1-CAM carboxy-terminus in pancreatic adenocarcinoma cells.

Chen MM, Lee CY, Leland HA, Silletti S.

Tumour Biol. 2011 Apr;32(2):347-57. doi: 10.1007/s13277-010-0127-4. Epub 2010 Nov 16.

6.

Inside-out regulation of L1 conformation, integrin binding, proteolysis, and concomitant cell migration.

Chen MM, Lee CY, Leland HA, Lin GY, Montgomery AM, Silletti S.

Mol Biol Cell. 2010 May 15;21(10):1671-85. doi: 10.1091/mbc.E09-10-0900. Epub 2010 Mar 24.

7.

Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.

Layton T, Stalens C, Gunderson F, Goodison S, Silletti S.

Am J Pathol. 2009 Dec;175(6):2625-36. doi: 10.2353/ajpath.2009.090543. Epub 2009 Nov 5.

8.

Tyrosine and serine phosphorylation regulate the conformation and subsequent threonine phosphorylation of the L1 cytoplasmic domain.

Chen MM, Leland HA, Lee CY, Silletti S.

Biochem Biophys Res Commun. 2009 Nov 13;389(2):257-64. doi: 10.1016/j.bbrc.2009.08.143. Epub 2009 Aug 29.

9.

Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.

Silletti S, Paku S, Raz A.

Pathol Oncol Res. 1997 Sep;3(3):230-54. doi: 10.1007/BF02899927.

10.

The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells.

Grzesiak JJ, Clopton P, Chalberg C, Smith K, Burton DW, Silletti S, Moossa AR, Deftos LJ, Bouvet M.

Pancreas. 2004 Aug;29(2):85-92.

PMID:
15257098
11.

Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion.

Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM.

J Biol Chem. 2004 Jul 9;279(28):28880-8. Epub 2004 May 5.

12.

Recognition of the neural chemoattractant Netrin-1 by integrins alpha6beta4 and alpha3beta1 regulates epithelial cell adhesion and migration.

Yebra M, Montgomery AM, Diaferia GR, Kaido T, Silletti S, Perez B, Just ML, Hildbrand S, Hurford R, Florkiewicz E, Tessier-Lavigne M, Cirulli V.

Dev Cell. 2003 Nov;5(5):695-707.

13.

Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.

Kessler TA, Pfeifer A, Silletti S, Mesters RM, Berdel WE, Verma I, Cheresh D.

Ann Hematol. 2002;81 Suppl 2:S69-70.

PMID:
12611083
14.

A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice.

Xiang R, Primus FJ, Ruehlmann JM, Niethammer AG, Silletti S, Lode HN, Dolman CS, Gillies SD, Reisfeld RA.

J Immunol. 2001 Oct 15;167(8):4560-5.

16.

Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.

Xiang R, Silletti S, Lode HN, Dolman CS, Ruehlmann JM, Niethammer AG, Pertl U, Gillies SD, Primus FJ, Reisfeld RA.

Clin Cancer Res. 2001 Mar;7(3 Suppl):856s-864s.

PMID:
11300483
17.

Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo.

Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):119-24.

18.

Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

Pfeifer A, Kessler T, Silletti S, Cheresh DA, Verma IM.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12227-32.

20.

A potential role for the plasmin(ogen) system in the posttranslational cleavage of the neural cell adhesion molecule L1.

Nayeem N, Silletti S, Yang X, Lemmon VP, Reisfeld RA, Stallcup WB, Montgomery AM.

J Cell Sci. 1999 Dec;112 ( Pt 24):4739-49.

21.

Matrix valency regulates integrin-mediated lymphoid adhesion via Syk kinase.

Stupack DG, Li E, Silletti SA, Kehler JA, Geahlen RL, Hahn K, Nemerow GR, Cheresh DA.

J Cell Biol. 1999 Feb 22;144(4):777-88.

24.

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.

Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA.

Cell. 1998 Feb 6;92(3):391-400.

25.

A single immunoglobulin-like domain of the human neural cell adhesion molecule L1 supports adhesion by multiple vascular and platelet integrins.

Felding-Habermann B, Silletti S, Mei F, Siu CH, Yip PM, Brooks PC, Cheresh DA, O'Toole TE, Ginsberg MH, Montgomery AM.

J Cell Biol. 1997 Dec 15;139(6):1567-81.

26.

Regulation of tumor cell motility by 12(S)-HETE.

Silletti S, Timar J, Honn KV, Raz A.

Adv Exp Med Biol. 1997;400B:683-92. Review. No abstract available.

PMID:
9547619
27.

Multiple use of a signal transduction pathway in tumor cell invasion.

Tímár J, Rásó E, Fazakas ZS, Silletti S, Raz A, Honn KV.

Anticancer Res. 1996 Nov-Dec;16(6A):3299-306.

PMID:
9042304
29.

Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.

Timar J, Trikha M, Szekeres K, Bazaz R, Tovari J, Silletti S, Raz A, Honn KV.

Cancer Res. 1996 Apr 15;56(8):1902-8.

30.

Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis.

Silletti S, Raz A.

Curr Top Microbiol Immunol. 1996;213 ( Pt 2):137-69. Review. No abstract available.

PMID:
9053289
31.
33.

Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.

Isoai A, Goto-Tsukamoto H, Yamori T, Oh-hara T, Tsuruo T, Silletti S, Raz A, Watanabe H, Akedo H, Kumagai H.

Cancer Res. 1994 Mar 1;54(5):1264-70.

34.

Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.

Timar J, Silletti S, Bazaz R, Raz A, Honn KV.

Int J Cancer. 1993 Dec 2;55(6):1003-10.

PMID:
8253518
35.

Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mapping.

Silletti S, Yao J, Sanford J, Mohammed A, Otto T, Wolman S, Raz A.

Int J Oncol. 1993 Nov;3(5):801-7.

PMID:
21573434
36.

Autocrine motility factor is a growth factor.

Silletti S, Raz A.

Biochem Biophys Res Commun. 1993 Jul 15;194(1):446-57.

PMID:
8392842
37.

Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.

Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, Raz A.

J Biol Chem. 1991 Jul 15;266(20):13442-8.

38.

Purification of B16-F1 melanoma autocrine motility factor and its receptor.

Silletti S, Watanabe H, Hogan V, Nabi IR, Raz A.

Cancer Res. 1991 Jul 1;51(13):3507-11.

39.

Tumor cell autocrine motility factor receptor.

Nabi IR, Watanabe H, Silletti S, Raz A.

EXS. 1991;59:163-77. Review.

PMID:
1655517

Supplemental Content

Loading ...
Support Center